Aarti Pharmalabs has closed the operations of its plant located Vapi, Gujarat following the directions received from the Gujarat Pollution Control Board (GPCB) under Section 33(A) of the Water (Prevention and Control of Pollution) Act, 1974, on 02 January 2025. Further, the GPCB has asked to submit a bank guarantee of Rs. 2,50,000/- for compliance assurance at the time of revocation and has also ordered to deposit interim Environment Damage Compensation amount as and when decided by the GPCB. Powered by Capital Market - Live News

Net profit of Aarti Pharmalabs rose 5.44% to Rs 54.62 crore in the quarter ended September 2024 as against Rs 51.80 crore during the previous quarter ended September 2023. Sales rose 4.15% to Rs 458.03 crore in the quarter ended September 2024 as against Rs 439.80 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales458.03439.80 4 OPM %20.4520.01 - PBDT92.6585.08 9 PBT71.7766.94 7 NP54.6251.80 5 Powered by Capital Market - Live News

Aarti Pharmalabs has announced that Mr. Nikhil Natu has tendered his resignation from the position of Company Secretary & Compliance Officer of the Company and has been relieved from his duties effective closing of business hours on 30 October 2024.Powered by Capital Market - Live News

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 28 October 2024.Powered by Capital Market - Live News

Net profit of Aarti Pharmalabs rose 17.75% to Rs 55.45 crore in the quarter ended June 2024 as against Rs 47.09 crore during the previous quarter ended June 2023. Sales rose 21.19% to Rs 555.49 crore in the quarter ended June 2024 as against Rs 458.36 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales555.49458.36 21 OPM %17.3618.52 - PBDT93.8481.18 16 PBT73.6863.98 15 NP55.4547.09 18 Powered by Capital Market - Live News